GLPwatch
Trials (2036)
Page 13 of 34.
- A Study With NLY01 in Subjects With Type 2 Diabetes
- The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)
- Effects of Insulin Glargine and Lixisenatide on the Brain
- Tirzepatide for the Treatment of Cannabis Use Disorder
- Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin
- The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
- Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)
- Antidiabetic Effects on Intrahepatic Fat
- Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure
- Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation
- Gut Hormones in Obesity, Nicotine and Alcohol Dependence
- The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
- Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
- Semaglutide (Wegovy) Treatment for Trichotillomania
- A Multiple-Dose Study of LY3502970 in Healthy Participants
- Study of the Effects of Intravenous Exenatide on Cardiac Repolarization
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
- GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
- Human Bioequivalence Test of Liraglutide Injection
- A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes
- Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)
- Effects of Semaglutide in HIV-Associated Lipohypertrophy
- The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture
- Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
- Dietary Peanuts and Nutrition-Related Outcomes
- Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
- A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes
- GLP-1 Receptor Targeting in Diabetic and Healthy Individuals
- ADJUnct Semaglutide Treatment in Type 1 Diabetes
- Tirzepatide in the Treatment of Endometrial Cancer
- The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus
- IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion
- Trial of Tirzepatide for the Treatment of Cannabis Use Disorder
- A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
- Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes
- COMMETS- Combination MCI Metabolic Syndrome
- Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
- A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide
- A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations
- Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
- Lecanemab for Early Onset Familial Alzheimer's Disease
- Liraglutide Effects on Epicardial Fat Inflammatory Genes
- DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists
- GLP1R-imaging in Hypoglycemia
- Semaglutide Effectiveness in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease in the Real World Practice
- Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
- Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)
- Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
- The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
- Clinical Study on the Improvement of Diabetic Neuropathic Pain by Liraglutide
- Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.
- The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes
- A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes
- Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
- Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients
- Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
- Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets